首页 > 最新文献

Surgery Today最新文献

英文 中文
Transanal total mesorectal excision for locally advanced rectal cancer following neoadjuvant chemoradiotherapy. 新辅助化放疗后经肛门全直肠系膜切除术治疗局部晚期直肠癌。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-04-08 DOI: 10.1007/s00595-025-03042-w
Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Ryuichiro Sawada, Yasufumi Koterazawa, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Yoshihiro Kakeji

Purpose: To examine the clinical impact of transanal total mesorectal excision (TaTME) for locally advanced rectal cancer after neoadjuvant chemoradiotherapy (NACRT).

Methods: This retrospective study included 91 patients undergoing surgery for rectal cancer after NACRT between 2011 and 2022. Among them, 24, 22, and 45 patients underwent open (Open), conventional laparoscopic (Lap), and TaTME surgeries, respectively. We compared their clinical outcomes.

Results: Operative time, blood loss, transfusion, morbidity, and hospital stay were significantly lower in the TaTME group than in the Open or Lap groups. The multivariate regression analyses identified only the TaTME approach as a significant factor for reducing morbidity. Both 3 yrear relapse-free survival (RFS) and local recurrence-free survival (LRFS) were significantly better in the TaTME group than in the Open or Lap groups (3 yr RFS: 94.7%, 80.4%, and 66.7%, and 3 yr LRFS: 100%, 90.5%, and 82.2% for the TaTME, Lap, and Open groups, respectively). Multivariate analyses of potential risk factors for recurrence identified body mass index, combined resection, and pathological stage, but not the TaTME approach, as significant predictors of recurrence.

Conclusion: TaTME reduced morbidity significantly in patients with locally advanced rectal cancer undergoing NACRT, compared with open or laparoscopic surgery.

{"title":"Transanal total mesorectal excision for locally advanced rectal cancer following neoadjuvant chemoradiotherapy.","authors":"Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Ryuichiro Sawada, Yasufumi Koterazawa, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Yoshihiro Kakeji","doi":"10.1007/s00595-025-03042-w","DOIUrl":"https://doi.org/10.1007/s00595-025-03042-w","url":null,"abstract":"<p><strong>Purpose: </strong>To examine the clinical impact of transanal total mesorectal excision (TaTME) for locally advanced rectal cancer after neoadjuvant chemoradiotherapy (NACRT).</p><p><strong>Methods: </strong>This retrospective study included 91 patients undergoing surgery for rectal cancer after NACRT between 2011 and 2022. Among them, 24, 22, and 45 patients underwent open (Open), conventional laparoscopic (Lap), and TaTME surgeries, respectively. We compared their clinical outcomes.</p><p><strong>Results: </strong>Operative time, blood loss, transfusion, morbidity, and hospital stay were significantly lower in the TaTME group than in the Open or Lap groups. The multivariate regression analyses identified only the TaTME approach as a significant factor for reducing morbidity. Both 3 yrear relapse-free survival (RFS) and local recurrence-free survival (LRFS) were significantly better in the TaTME group than in the Open or Lap groups (3 yr RFS: 94.7%, 80.4%, and 66.7%, and 3 yr LRFS: 100%, 90.5%, and 82.2% for the TaTME, Lap, and Open groups, respectively). Multivariate analyses of potential risk factors for recurrence identified body mass index, combined resection, and pathological stage, but not the TaTME approach, as significant predictors of recurrence.</p><p><strong>Conclusion: </strong>TaTME reduced morbidity significantly in patients with locally advanced rectal cancer undergoing NACRT, compared with open or laparoscopic surgery.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impedance-based detection of cervical lymph-node involvement in thyroid cancer patients: a human model study.
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-04-03 DOI: 10.1007/s00595-025-03033-x
Hossein Ataee, Mohammad Seraj, Reihane Mahdavi, Ali Fardoost, Abdollah Shafiee, Khosro Shamsi, Mohammadreza Fattahi, Hojat Ebrahiminik, Parisa Hoseinpour, Shahram Sane, Mehran Ghazimoghaddam, Mohammad Esmaeel Akbari, Mohammad Abdolahad

Purpose: Current diagnostic modalities for differentiating between benign and malignant cervical lymph nodes in patients with thyroid cancer are imprecise and time-consuming. The real-time intraoperative detection of malignancy in suspicious lesions could improve the medical management of these patients. This human study was undertaken to evaluate a precise, newly developed Electrical Lymph-Node Scanning (ELS) system to facilitate the effective treatment of cervical LNs in thyroid cancer patients.

Methods: Using the ELS, we examined a collective 109 radiologically suspicious lymph nodes from 36 patients after dissection and compared the ELS results with the histopathological findings.

Results: A total of 27 involved lymph nodes were correctly diagnosed, while 75 reactive or free lymph nodes were correctly identified as uninvolved lymph nodes by ELS (as 3 false negatives and 4 false positives) with total sensitivity and specificity of 90% and 94.9%, respectively. The corresponding negative and positive predictive values were 87.1% and 96.2%, respectively.

Conclusions: Results from this clinical study demonstrate the value of the ELS as a surgical assist adjunct for differentiating equivocal lesions during neck dissection surgery for patients with different types of thyroid cancer.

{"title":"Impedance-based detection of cervical lymph-node involvement in thyroid cancer patients: a human model study.","authors":"Hossein Ataee, Mohammad Seraj, Reihane Mahdavi, Ali Fardoost, Abdollah Shafiee, Khosro Shamsi, Mohammadreza Fattahi, Hojat Ebrahiminik, Parisa Hoseinpour, Shahram Sane, Mehran Ghazimoghaddam, Mohammad Esmaeel Akbari, Mohammad Abdolahad","doi":"10.1007/s00595-025-03033-x","DOIUrl":"https://doi.org/10.1007/s00595-025-03033-x","url":null,"abstract":"<p><strong>Purpose: </strong>Current diagnostic modalities for differentiating between benign and malignant cervical lymph nodes in patients with thyroid cancer are imprecise and time-consuming. The real-time intraoperative detection of malignancy in suspicious lesions could improve the medical management of these patients. This human study was undertaken to evaluate a precise, newly developed Electrical Lymph-Node Scanning (ELS) system to facilitate the effective treatment of cervical LNs in thyroid cancer patients.</p><p><strong>Methods: </strong>Using the ELS, we examined a collective 109 radiologically suspicious lymph nodes from 36 patients after dissection and compared the ELS results with the histopathological findings.</p><p><strong>Results: </strong>A total of 27 involved lymph nodes were correctly diagnosed, while 75 reactive or free lymph nodes were correctly identified as uninvolved lymph nodes by ELS (as 3 false negatives and 4 false positives) with total sensitivity and specificity of 90% and 94.9%, respectively. The corresponding negative and positive predictive values were 87.1% and 96.2%, respectively.</p><p><strong>Conclusions: </strong>Results from this clinical study demonstrate the value of the ELS as a surgical assist adjunct for differentiating equivocal lesions during neck dissection surgery for patients with different types of thyroid cancer.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic significance of the liver stiffness value on magnetic resonance imaging elastography in patients undergoing hepatectomy for hepatocellular carcinoma.
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-04-03 DOI: 10.1007/s00595-025-03034-w
Hiroto Chiba, Naoya Sato, Atsushi Ozeki, Ryota Sugawara, Takayasu Azuma, Shigeyuki Tsukida, Makoto Muto, Junichiro Haga, Yasuhide Kofunato, Teruhide Ishigame, Takashi Kimura, Akira Kenjo, Shigeru Marubashi

Synopsis: This study shows the utility of magnetic resonance imaging elastography as an independent predictor of the postoperative recurrence of hepatocellular carcinoma.

Purpose: Accurate assessment of postoperative recurrence risk is crucial for the perioperative management of patients undergoing surgical resection for hepatocellular carcinoma (HCC). Magnetic resonance imaging elastography (MRE) has emerged as a noninvasive tool for assessing liver fibrosis. This study evaluated whether MRE independently predicts HCC recurrence more effectively than well-known oncological factors, including pathological findings.

Methods: The subjects of this retrospective observational study were HCC patients who underwent preoperative MRE and hepatectomy between 2013 and 2023. Data collected included demographics, laboratory findings, imaging, pathology, operative details, and prognosis. Patients were followed up for at least 1 year after hepatectomy or until recurrence.

Results: Recurrence developed in 46 of 100 patients. Multivariable Cox regression analysis for overall recurrence identified MRE ≥ 3.7 kPa (hazard ratio [HR] 3.161, p = 0.021), the FIB-4 index (HR 3.176, p = 0.001), tumor size > 5 cm (HR 5.893, p < 0.001), invasive growth pattern (HR 2.375, p = 0.036), METAVIR F3-4 (HR 2.562, p = 0.046), and venous invasion (HR 10.622, p < 0.001) as risk factors. The recurrence-free rate at 1 year for patients with MRE ≥ 3.7 kPa was lower than for those with MRE < 3.7 kPa (72.0% vs. 92.0%, p = 0.017).

Conclusions: Preoperative MRE predicts postoperative HCC recurrence, underscoring its utility in risk stratification.

{"title":"Prognostic significance of the liver stiffness value on magnetic resonance imaging elastography in patients undergoing hepatectomy for hepatocellular carcinoma.","authors":"Hiroto Chiba, Naoya Sato, Atsushi Ozeki, Ryota Sugawara, Takayasu Azuma, Shigeyuki Tsukida, Makoto Muto, Junichiro Haga, Yasuhide Kofunato, Teruhide Ishigame, Takashi Kimura, Akira Kenjo, Shigeru Marubashi","doi":"10.1007/s00595-025-03034-w","DOIUrl":"https://doi.org/10.1007/s00595-025-03034-w","url":null,"abstract":"<p><strong>Synopsis: </strong>This study shows the utility of magnetic resonance imaging elastography as an independent predictor of the postoperative recurrence of hepatocellular carcinoma.</p><p><strong>Purpose: </strong>Accurate assessment of postoperative recurrence risk is crucial for the perioperative management of patients undergoing surgical resection for hepatocellular carcinoma (HCC). Magnetic resonance imaging elastography (MRE) has emerged as a noninvasive tool for assessing liver fibrosis. This study evaluated whether MRE independently predicts HCC recurrence more effectively than well-known oncological factors, including pathological findings.</p><p><strong>Methods: </strong>The subjects of this retrospective observational study were HCC patients who underwent preoperative MRE and hepatectomy between 2013 and 2023. Data collected included demographics, laboratory findings, imaging, pathology, operative details, and prognosis. Patients were followed up for at least 1 year after hepatectomy or until recurrence.</p><p><strong>Results: </strong>Recurrence developed in 46 of 100 patients. Multivariable Cox regression analysis for overall recurrence identified MRE ≥ 3.7 kPa (hazard ratio [HR] 3.161, p = 0.021), the FIB-4 index (HR 3.176, p = 0.001), tumor size > 5 cm (HR 5.893, p < 0.001), invasive growth pattern (HR 2.375, p = 0.036), METAVIR F3-4 (HR 2.562, p = 0.046), and venous invasion (HR 10.622, p < 0.001) as risk factors. The recurrence-free rate at 1 year for patients with MRE ≥ 3.7 kPa was lower than for those with MRE < 3.7 kPa (72.0% vs. 92.0%, p = 0.017).</p><p><strong>Conclusions: </strong>Preoperative MRE predicts postoperative HCC recurrence, underscoring its utility in risk stratification.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143773264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between the C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index and the prognosis of gastric cancer patients after gastrectomy: a systematic review and meta-analysis. C反应蛋白(CRP)-白蛋白-淋巴细胞(CALLY)指数与胃切除术后胃癌患者预后的相关性:系统综述和荟萃分析。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-04-01 Epub Date: 2024-08-19 DOI: 10.1007/s00595-024-02921-y
Jinquan Li, Shanzhong Zhang, Xiaosheng Hu, Tao Huang, Mingmin Chen

The C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) index is an established immuno-nutritional scoring system. We screened relevant literature from the major databases up until May, 2024, and extracted the data for analysis. A total of 2829 gastric cancer (GC) patients from six studies were included in this meta-analysis, the results of which revealed that the CALLY index was an independent prognostic factor for OS and RFS in both univariate analyses and multivariate analyses, and that a high CALLY index was a favorable prognostic factor. Moreover, GC patients in the high CALLY index group seemed to have better 5-year OS and 5-year RFS than those in the low CALLY index group. There was a higher proportion of patients with T1 status in the high CALLY index group than in the low CALLY index group. However, the opposite results were found in the analyses of lymph node metastasis positivity, lymph-vascular invasion positivity, postoperative complications, differentiated histological type, anastomotic leakage, and adjuvant chemotherapy. The present meta-analysis concluded that the CALLY index was a simple and useful independent prognostic biomarker for GC patients after gastrectomy.

C反应蛋白(CRP)-白蛋白-淋巴细胞(CALLY)指数是一种成熟的免疫营养评分系统。我们从主要数据库中筛选了截至 2024 年 5 月的相关文献,并提取数据进行分析。结果显示,在单变量分析和多变量分析中,CALLY指数是OS和RFS的独立预后因素,高CALLY指数是一个有利的预后因素。此外,与低CALLY指数组相比,高CALLY指数组GC患者的5年OS和5年RFS似乎更好。高 CALLY 指数组中 T1 状态患者的比例高于低 CALLY 指数组。然而,在淋巴结转移阳性、淋巴管侵犯阳性、术后并发症、分化组织学类型、吻合口漏和辅助化疗的分析中却发现了相反的结果。本荟萃分析认为,CALLY指数是胃切除术后GC患者的一个简单而有用的独立预后生物标志物。
{"title":"Correlation between the C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index and the prognosis of gastric cancer patients after gastrectomy: a systematic review and meta-analysis.","authors":"Jinquan Li, Shanzhong Zhang, Xiaosheng Hu, Tao Huang, Mingmin Chen","doi":"10.1007/s00595-024-02921-y","DOIUrl":"10.1007/s00595-024-02921-y","url":null,"abstract":"<p><p>The C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) index is an established immuno-nutritional scoring system. We screened relevant literature from the major databases up until May, 2024, and extracted the data for analysis. A total of 2829 gastric cancer (GC) patients from six studies were included in this meta-analysis, the results of which revealed that the CALLY index was an independent prognostic factor for OS and RFS in both univariate analyses and multivariate analyses, and that a high CALLY index was a favorable prognostic factor. Moreover, GC patients in the high CALLY index group seemed to have better 5-year OS and 5-year RFS than those in the low CALLY index group. There was a higher proportion of patients with T1 status in the high CALLY index group than in the low CALLY index group. However, the opposite results were found in the analyses of lymph node metastasis positivity, lymph-vascular invasion positivity, postoperative complications, differentiated histological type, anastomotic leakage, and adjuvant chemotherapy. The present meta-analysis concluded that the CALLY index was a simple and useful independent prognostic biomarker for GC patients after gastrectomy.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"483-491"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced safety in central venous catheterization performed by Japanese board-certified pediatric surgeons: a retrospective single-center study. 一项回顾性单中心研究:由日本经委员会认证的儿科外科医生进行的中心静脉导管插入术安全性的提高。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-04-01 Epub Date: 2024-08-20 DOI: 10.1007/s00595-024-02929-4
Yohei Sanmoto, Yudai Goto, Kouji Masumoto

Purpose: Board certification by the Japanese Society of Pediatric Surgeons is awarded to pediatric surgeons with substantial surgical experience and academic achievement. However, to date, the surgical performance or outcomes of certified surgeons have not been reported. This study examined the relationship between board certification and surgical outcomes of central venous catheterization.

Methods: This retrospective single-center study was conducted between April 2017 and May 2024. Patients were classified based on whether their procedures were performed by board-certified or non-certified surgeons, and their backgrounds and surgical outcomes were compared. In addition, multivariate analysis was performed to identify the factors associated with prolonged operative time.

Results: This study included 112 procedures: 26 performed by board-certified surgeons and 86 performed by non-certified surgeons. There were no significant differences in the age, sex, weight, or primary diagnosis between the groups; however, surgery-associated complications were significantly more common in the non-certified surgeon group than in the board-certified surgeon group (15.1% vs. 0%, P = 0.036). In addition, factors independently associated with a prolonged operative time included weight < 10 kg, left-sided approach, implantable port device use, and < 7 years of postgraduate experience for the surgeon.

Conclusion: Board certification was associated with a significant reduction in surgery-associated complications during central venous catheterization.

目的:日本小儿外科医生协会向具有丰富手术经验和学术成就的小儿外科医生颁发委员会认证。然而,迄今为止,尚未有关于获得认证的外科医生的手术表现或结果的报道。本研究探讨了委员会认证与中心静脉导管插入术的手术效果之间的关系:这项回顾性单中心研究在 2017 年 4 月至 2024 年 5 月期间进行。根据患者的手术是否由获得董事会认证或未获得认证的外科医生进行分类,并对其背景和手术结果进行比较。此外,还进行了多变量分析,以确定与手术时间延长相关的因素:本研究包括 112 例手术:结果:这项研究包括 112 例手术:26 例由获得医学会认证的外科医生实施,86 例由未获得认证的外科医生实施。两组患者在年龄、性别、体重或主要诊断方面无明显差异;但非认证外科医生组的手术相关并发症发生率明显高于认证外科医生组(15.1% vs. 0%,P = 0.036)。此外,与手术时间延长独立相关的因素还包括体重:获得委员会认证可显著减少中心静脉导管插入术中与手术相关的并发症。
{"title":"Enhanced safety in central venous catheterization performed by Japanese board-certified pediatric surgeons: a retrospective single-center study.","authors":"Yohei Sanmoto, Yudai Goto, Kouji Masumoto","doi":"10.1007/s00595-024-02929-4","DOIUrl":"10.1007/s00595-024-02929-4","url":null,"abstract":"<p><strong>Purpose: </strong>Board certification by the Japanese Society of Pediatric Surgeons is awarded to pediatric surgeons with substantial surgical experience and academic achievement. However, to date, the surgical performance or outcomes of certified surgeons have not been reported. This study examined the relationship between board certification and surgical outcomes of central venous catheterization.</p><p><strong>Methods: </strong>This retrospective single-center study was conducted between April 2017 and May 2024. Patients were classified based on whether their procedures were performed by board-certified or non-certified surgeons, and their backgrounds and surgical outcomes were compared. In addition, multivariate analysis was performed to identify the factors associated with prolonged operative time.</p><p><strong>Results: </strong>This study included 112 procedures: 26 performed by board-certified surgeons and 86 performed by non-certified surgeons. There were no significant differences in the age, sex, weight, or primary diagnosis between the groups; however, surgery-associated complications were significantly more common in the non-certified surgeon group than in the board-certified surgeon group (15.1% vs. 0%, P = 0.036). In addition, factors independently associated with a prolonged operative time included weight < 10 kg, left-sided approach, implantable port device use, and < 7 years of postgraduate experience for the surgeon.</p><p><strong>Conclusion: </strong>Board certification was associated with a significant reduction in surgery-associated complications during central venous catheterization.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"537-543"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world outcomes of stage II and III colorectal cancers treated by postoperative adjuvant chemotherapy based on the mismatch repair status. 基于错配修复状态的 II 期和 III 期结直肠癌术后辅助化疗的实际疗效。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-04-01 Epub Date: 2024-09-09 DOI: 10.1007/s00595-024-02932-9
Yoshinori Iwata, Chihiro Tanaka, Shinya Ohno, Tomonari Suetsugu, Hideharu Tanaka, Taku Watanabe, Shuji Komori, Narutoshi Nagao, Masaki Katayama, Masahiko Kawai

Purpose: In Japan, immunohistochemistry for mismatch repair (MMR) proteins targeted at stage II and III colorectal cancers (CRCs) has been covered by national insurance since October, 2022. This study aimed to clarify the long-term outcomes of patients with stage II and III CRCs receiving postoperative adjuvant chemotherapy based on their MMR status.

Methods: The outcomes of 640 patients who underwent radical surgery for stage II and III CRCs were analyzed retrospectively.

Results: Deficient MMR (dMMR) was diagnosed in 41 (13.3%) patients with stage II and 28 (9.1%) patients with stage III CRC. The overall survival and recurrence rates were not significantly different between the patients with stage II and those with stage III CRC. The risk factors for recurrence among those with stage II CRC were tumors on the left side, T4 disease, and the presence of BRAF wild type. The recurrence rates were lower in the stage II CRC patients with sporadic dMMR than in those with suspected Lynch syndrome (LS). The first site of recurrence was more frequently the peritoneum or distant lymph node in patients with dMMR.

Conclusions: Stage II CRC patients with sporadic dMMR were found to have a very good prognosis. On the other hand, peritoneal dissemination or distant lymph node metastasis tended to develop in patients with dMMR.

目的:在日本,自2022年10月起,针对II期和III期结直肠癌(CRC)的错配修复(MMR)蛋白免疫组化已被纳入国家保险范围。本研究旨在根据 MMR 状态,明确接受术后辅助化疗的 II 期和 III 期 CRC 患者的长期疗效:方法:回顾性分析了640名接受根治术的II期和III期CRC患者的疗效:结果:41例(13.3%)II期CRC患者和28例(9.1%)III期CRC患者被诊断出缺乏MMR(dMMR)。II 期和 III 期 CRC 患者的总生存率和复发率无明显差异。II 期 CRC 患者复发的风险因素是肿瘤位于左侧、T4 病变和 BRAF 野生型。散发性 dMMR II 期 CRC 患者的复发率低于疑似林奇综合征(LS)患者。dMMR患者的第一个复发部位多为腹膜或远处淋巴结:结论:散发性 dMMR 的 II 期 CRC 患者预后良好。结论:散发性 dMMR 的 II 期 CRC 患者预后非常好,而 dMMR 患者往往会出现腹膜播散或远处淋巴结转移。
{"title":"Real-world outcomes of stage II and III colorectal cancers treated by postoperative adjuvant chemotherapy based on the mismatch repair status.","authors":"Yoshinori Iwata, Chihiro Tanaka, Shinya Ohno, Tomonari Suetsugu, Hideharu Tanaka, Taku Watanabe, Shuji Komori, Narutoshi Nagao, Masaki Katayama, Masahiko Kawai","doi":"10.1007/s00595-024-02932-9","DOIUrl":"10.1007/s00595-024-02932-9","url":null,"abstract":"<p><strong>Purpose: </strong>In Japan, immunohistochemistry for mismatch repair (MMR) proteins targeted at stage II and III colorectal cancers (CRCs) has been covered by national insurance since October, 2022. This study aimed to clarify the long-term outcomes of patients with stage II and III CRCs receiving postoperative adjuvant chemotherapy based on their MMR status.</p><p><strong>Methods: </strong>The outcomes of 640 patients who underwent radical surgery for stage II and III CRCs were analyzed retrospectively.</p><p><strong>Results: </strong>Deficient MMR (dMMR) was diagnosed in 41 (13.3%) patients with stage II and 28 (9.1%) patients with stage III CRC. The overall survival and recurrence rates were not significantly different between the patients with stage II and those with stage III CRC. The risk factors for recurrence among those with stage II CRC were tumors on the left side, T4 disease, and the presence of BRAF wild type. The recurrence rates were lower in the stage II CRC patients with sporadic dMMR than in those with suspected Lynch syndrome (LS). The first site of recurrence was more frequently the peritoneum or distant lymph node in patients with dMMR.</p><p><strong>Conclusions: </strong>Stage II CRC patients with sporadic dMMR were found to have a very good prognosis. On the other hand, peritoneal dissemination or distant lymph node metastasis tended to develop in patients with dMMR.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"492-501"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serial positron-emission tomography after induction therapy as a predictor of prognostic outcomes for patients with thymic carcinoma. 诱导治疗后连续正电子发射断层扫描作为胸腺癌患者预后结果的预测因子。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-04-01 Epub Date: 2024-12-05 DOI: 10.1007/s00595-024-02954-3
Yudai Miyashita, Takashi Kanou, Tomomi Isono, Hiroto Ishida, Hideki Nagata, Teiko Sakurai, Kenji Kimura, Eriko Fukui, Toru Kimura, Naoko Ose, Tadashi Watabe, Yasushi Shintani

Purpose: To investigate the role of 18F-fluorodeoxy glucose-positron emission tomography/computed tomography (FDG-PET/CT) to assess pathological response and prognosis after induction therapy in patients with thymic carcinoma.

Methods: The subjects of this retrospective study were 18 patients with thymic carcinoma who underwent FDG-PET, before and after induction therapy. We measured the maximum standardized uptake value (SUVmax) of the tumor and analyzed the correlation between the change in SUVmax and pathological response or recurrence.

Results: Induction therapy led to a reduction in both the tumor size and SUVmax in most patients. A strong correlation (Pearson coefficient = 0.90, p < 0.0001) was observed between the changes in tumor size and SUVmax. Although the SUVmax and tumor size showed no association with the pathological response, an SUVmax change > 50% predicted lower recurrence rates (p = 0.03).

Conclusion: Changes in the SUVmax following induction therapy may serve as a valuable predictor of recurrence in patients with thymic carcinoma. This finding highlights the potential of FDG-PET as a tool for patient monitoring and prognostication of this rare subset of carcinomas. Further studies are warranted to validate these results and standardize the FDG-PET protocols for optimal clinical use.

目的:探讨18f -氟脱氧葡萄糖-正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)在胸腺癌诱导治疗后病理反应及预后评价中的作用。方法:回顾性研究18例胸腺癌患者,在诱导治疗前后行FDG-PET检查。我们测量了肿瘤的最大标准化摄取值(SUVmax),并分析了SUVmax变化与病理反应或复发的相关性。结果:诱导治疗使大多数患者的肿瘤大小和SUVmax均减小。相关性强(Pearson系数= 0.90,p 50%预测复发率较低(p = 0.03)。结论:诱导治疗后SUVmax的变化可能是胸腺癌患者复发的一个有价值的预测指标。这一发现突出了FDG-PET作为患者监测和预测这一罕见癌症亚群的工具的潜力。需要进一步的研究来验证这些结果,并使FDG-PET方案标准化,以获得最佳的临床应用。
{"title":"Serial positron-emission tomography after induction therapy as a predictor of prognostic outcomes for patients with thymic carcinoma.","authors":"Yudai Miyashita, Takashi Kanou, Tomomi Isono, Hiroto Ishida, Hideki Nagata, Teiko Sakurai, Kenji Kimura, Eriko Fukui, Toru Kimura, Naoko Ose, Tadashi Watabe, Yasushi Shintani","doi":"10.1007/s00595-024-02954-3","DOIUrl":"10.1007/s00595-024-02954-3","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the role of <sup>18</sup>F-fluorodeoxy glucose-positron emission tomography/computed tomography (FDG-PET/CT) to assess pathological response and prognosis after induction therapy in patients with thymic carcinoma.</p><p><strong>Methods: </strong>The subjects of this retrospective study were 18 patients with thymic carcinoma who underwent FDG-PET, before and after induction therapy. We measured the maximum standardized uptake value (SUVmax) of the tumor and analyzed the correlation between the change in SUVmax and pathological response or recurrence.</p><p><strong>Results: </strong>Induction therapy led to a reduction in both the tumor size and SUVmax in most patients. A strong correlation (Pearson coefficient = 0.90, p < 0.0001) was observed between the changes in tumor size and SUVmax. Although the SUVmax and tumor size showed no association with the pathological response, an SUVmax change > 50% predicted lower recurrence rates (p = 0.03).</p><p><strong>Conclusion: </strong>Changes in the SUVmax following induction therapy may serve as a valuable predictor of recurrence in patients with thymic carcinoma. This finding highlights the potential of FDG-PET as a tool for patient monitoring and prognostication of this rare subset of carcinomas. Further studies are warranted to validate these results and standardize the FDG-PET protocols for optimal clinical use.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"569-578"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142787064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic impact of abdominal aortic calcification in patients who underwent hepatectomy for intrahepatic cholangiocarcinoma. 肝内胆管癌肝切除术患者腹主动脉钙化的预后影响
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-04-01 Epub Date: 2024-08-20 DOI: 10.1007/s00595-024-02922-x
Yuto Yamahata, Takeshi Gocho, Kenei Furukawa, Koichiro Haruki, Shinji Onda, Yoshihiro Shirai, Masashi Tsunematsu, Tomohiko Taniai, Mitsuru Yanagaki, Michinori Matsumoto, Ryoga Hamura, Norimitsu Okui, Yoshiaki Tanji, Toru Ikegami

Purpose: Abdominal aortic calcification (AAC), an indicator of systemic arteriosclerosis, is associated with short- and long-term outcomes in malignancies. We investigated the prognostic impact of AAC in patients who underwent hepatectomy for intrahepatic cholangiocarcinoma (IHCC).

Methods: The study cohort comprised 46 patients who underwent hepatectomy for IHCC between January 2008 and September 2020. The AAC volume measured by preoperative computed tomography was used to construct a model of the calcified segment from the renal artery to the common iliac artery bifurcation. We investigated the relationship between AAC and the long-term outcomes. The AAC volume cutoff value was calculated from a receiver-operating characteristic curve based on the three-year survival.

Results: According to our cutoff AAC volume of 3,700 mm3, 11 patients (24%) had high AAC volumes. The high-AAC group was significantly older than the low-AAC group (73 vs. 62 years old, p < 0.01). A multivariate analysis of the cancer-specific survival showed that a high serum carbohydrate antigen 19-9 concentration (hazard ratio [HR] 5.57, p = 0.01), high AAC volume (HR 3.03, p = 0.04), and [high?] T3 or T4 levels (HR 9.05, p < 0.01) were independently associated with a poor prognosis.

Conclusion: AAC is a useful predictor of the oncological prognosis in patients undergoing hepatectomy for IHCC.

目的:腹主动脉钙化(AAC)是全身动脉硬化的一个指标,与恶性肿瘤的短期和长期预后有关。我们研究了腹主动脉钙化对肝内胆管癌(IHCC)肝切除术患者预后的影响:研究队列包括2008年1月至2020年9月期间因IHCC接受肝切除术的46例患者。术前计算机断层扫描测量的AAC体积被用于构建从肾动脉到髂总动脉分叉处的钙化段模型。我们研究了AAC与长期预后之间的关系。根据三年存活率的接收者操作特征曲线计算出了AAC体积的临界值:根据我们的 AAC 截断值 3,700 mm3,11 名患者(24%)的 AAC 容量较大。高AAC组患者的年龄明显高于低AAC组(73岁对62岁,P 结论:AAC是预测癌症的有效指标:AAC是预测IHCC肝切除术患者肿瘤预后的有效指标。
{"title":"Prognostic impact of abdominal aortic calcification in patients who underwent hepatectomy for intrahepatic cholangiocarcinoma.","authors":"Yuto Yamahata, Takeshi Gocho, Kenei Furukawa, Koichiro Haruki, Shinji Onda, Yoshihiro Shirai, Masashi Tsunematsu, Tomohiko Taniai, Mitsuru Yanagaki, Michinori Matsumoto, Ryoga Hamura, Norimitsu Okui, Yoshiaki Tanji, Toru Ikegami","doi":"10.1007/s00595-024-02922-x","DOIUrl":"10.1007/s00595-024-02922-x","url":null,"abstract":"<p><strong>Purpose: </strong>Abdominal aortic calcification (AAC), an indicator of systemic arteriosclerosis, is associated with short- and long-term outcomes in malignancies. We investigated the prognostic impact of AAC in patients who underwent hepatectomy for intrahepatic cholangiocarcinoma (IHCC).</p><p><strong>Methods: </strong>The study cohort comprised 46 patients who underwent hepatectomy for IHCC between January 2008 and September 2020. The AAC volume measured by preoperative computed tomography was used to construct a model of the calcified segment from the renal artery to the common iliac artery bifurcation. We investigated the relationship between AAC and the long-term outcomes. The AAC volume cutoff value was calculated from a receiver-operating characteristic curve based on the three-year survival.</p><p><strong>Results: </strong>According to our cutoff AAC volume of 3,700 mm<sup>3</sup>, 11 patients (24%) had high AAC volumes. The high-AAC group was significantly older than the low-AAC group (73 vs. 62 years old, p < 0.01). A multivariate analysis of the cancer-specific survival showed that a high serum carbohydrate antigen 19-9 concentration (hazard ratio [HR] 5.57, p = 0.01), high AAC volume (HR 3.03, p = 0.04), and [high?] T3 or T4 levels (HR 9.05, p < 0.01) were independently associated with a poor prognosis.</p><p><strong>Conclusion: </strong>AAC is a useful predictor of the oncological prognosis in patients undergoing hepatectomy for IHCC.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"544-551"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the anatomical basis of anorectal fistulas and their surgical management: exploring different types for enhanced precision and safety.
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-04-01 Epub Date: 2025-01-31 DOI: 10.1007/s00595-025-02995-2
Asim M Almughamsi, Yasir Hassan Elhassan

Anorectal fistulas remain one of the most challenging conditions in colorectal surgery and require precise anatomical knowledge for successful management. This comprehensive review synthesizes the current evidence on the anatomical foundations of fistula development and treatment, particularly focusing on the cryptoglandular hypothesis and its clinical implications. A systematic analysis of the recent literature has examined the relationship between anatomical structures and fistula formation, classification systems, diagnostic modalities, and therapeutic approaches. The review revealed that anatomical considerations fundamentally influence treatment outcomes, with modern imaging techniques achieving up to 98% accuracy in delineating fistula anatomy. Key findings demonstrate that surgical success rates vary significantly based on anatomical complexity: 92-97% for simple fistulas versus 40-95% for complex cases using sphincter-sparing techniques. Emerging minimally invasive approaches and regenerative therapies, including mesenchymal stem cells, show promising results with 50-60% healing rates in complex cases. Special considerations are needed for complex cases such as Crohn's disease-related and rectovaginal fistulas. This review provides surgeons with an evidence-based framework for selecting optimal treatment strategies based on anatomical considerations, emphasizing the importance of preserving the anal sphincter function while achieving complete fistula eradication. Integrating advanced imaging, surgical techniques, and emerging therapies offers new possibilities for improving patient outcomes. This review aimed to bridge the gap between anatomical knowledge and practical surgical application, enhance clinical decision-making, and improve patient outcomes in anorectal fistula management.

{"title":"Understanding the anatomical basis of anorectal fistulas and their surgical management: exploring different types for enhanced precision and safety.","authors":"Asim M Almughamsi, Yasir Hassan Elhassan","doi":"10.1007/s00595-025-02995-2","DOIUrl":"10.1007/s00595-025-02995-2","url":null,"abstract":"<p><p>Anorectal fistulas remain one of the most challenging conditions in colorectal surgery and require precise anatomical knowledge for successful management. This comprehensive review synthesizes the current evidence on the anatomical foundations of fistula development and treatment, particularly focusing on the cryptoglandular hypothesis and its clinical implications. A systematic analysis of the recent literature has examined the relationship between anatomical structures and fistula formation, classification systems, diagnostic modalities, and therapeutic approaches. The review revealed that anatomical considerations fundamentally influence treatment outcomes, with modern imaging techniques achieving up to 98% accuracy in delineating fistula anatomy. Key findings demonstrate that surgical success rates vary significantly based on anatomical complexity: 92-97% for simple fistulas versus 40-95% for complex cases using sphincter-sparing techniques. Emerging minimally invasive approaches and regenerative therapies, including mesenchymal stem cells, show promising results with 50-60% healing rates in complex cases. Special considerations are needed for complex cases such as Crohn's disease-related and rectovaginal fistulas. This review provides surgeons with an evidence-based framework for selecting optimal treatment strategies based on anatomical considerations, emphasizing the importance of preserving the anal sphincter function while achieving complete fistula eradication. Integrating advanced imaging, surgical techniques, and emerging therapies offers new possibilities for improving patient outcomes. This review aimed to bridge the gap between anatomical knowledge and practical surgical application, enhance clinical decision-making, and improve patient outcomes in anorectal fistula management.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"457-474"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143067978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of perioperative synbiotics treatment in living-donor liver transplantation after induction of early enteral nutrition. 早期肠内营养诱导后,活体肝移植围手术期合成益生菌治疗的影响。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-04-01 Epub Date: 2024-08-19 DOI: 10.1007/s00595-024-02918-7
Shohei Yoshiya, Shinji Itoh, Takeo Toshima, Yuki Bekki, Takuma Izumi, Norifumi Iseda, Yuriko Tsutsui, Katsuya Toshida, Yuki Nakayama, Takuma Ishikawa, Tomoharu Yoshizumi

Purpose: Infectious complications, particularly post-transplant sepsis, have a critical impact on postoperative outcomes. This study examined the effects of perioperative synbiotic treatment on postoperative outcomes in patients receiving early enteral nutrition.

Methods: We reviewed 210 living-donor liver transplantation procedures and retrospectively analyzed the postoperative outcomes with and without perioperative synbiotic treatment (live lactic acid bacteria, bifidobacteria, and oligosaccharides) 5 days before and after living-donor liver transplantation.

Results: The synbiotic group (n = 34) had significantly fewer male donors (38.2% vs. 61.9%, p = 0.011) and a higher proportion of ABO-incompatible grafts (52.9% vs. 25.6%, p = 0.021) than the non-synbiotic group (n = 176). The incidence of sepsis was significantly lower in the synbiotic group than in the non-synbiotic group (0% vs. 7.4%, p = 0.029), with a lower incidence rate of sepsis due to bacteremia with intestinal bacteria (0% vs. 4.6%, p = 0.089). There were no significant differences in the proportions of acute rejection, small-for-size graft syndrome, or postoperative liver function between the two groups. Furthermore, there was no significant difference in the graft survival rates after LDLT between two groups. (p = 0.24).

Conclusion: Perioperative synbiotic treatment prevents post-transplant sepsis, even with early enteral nutrition.

目的:感染并发症,尤其是移植后败血症,对术后预后有着至关重要的影响。本研究探讨了围手术期合生元治疗对接受早期肠内营养患者术后效果的影响:我们回顾了 210 例活体肝移植手术,并回顾性分析了活体肝移植手术前后 5 天使用和未使用围手术期益生菌(活乳酸菌、双歧杆菌和低聚糖)治疗的术后效果:结果:与非同步生物组(n = 176)相比,同步生物组(n = 34)男性供体明显较少(38.2% vs. 61.9%,p = 0.011),ABO不相容移植物的比例也较高(52.9% vs. 25.6%,p = 0.021)。合成生化组的败血症发生率明显低于非合成生化组(0% vs. 7.4%,p = 0.029),其中肠道细菌引起的败血症发生率较低(0% vs. 4.6%,p = 0.089)。两组急性排斥反应、小尺寸移植物综合征或术后肝功能的比例无明显差异。此外,两组 LDLT 术后的移植物存活率也无明显差异(P = 0.24)。(P=0.24):结论:围手术期合生元治疗可预防移植后败血症,即使早期肠内营养也是如此。
{"title":"The impact of perioperative synbiotics treatment in living-donor liver transplantation after induction of early enteral nutrition.","authors":"Shohei Yoshiya, Shinji Itoh, Takeo Toshima, Yuki Bekki, Takuma Izumi, Norifumi Iseda, Yuriko Tsutsui, Katsuya Toshida, Yuki Nakayama, Takuma Ishikawa, Tomoharu Yoshizumi","doi":"10.1007/s00595-024-02918-7","DOIUrl":"10.1007/s00595-024-02918-7","url":null,"abstract":"<p><strong>Purpose: </strong>Infectious complications, particularly post-transplant sepsis, have a critical impact on postoperative outcomes. This study examined the effects of perioperative synbiotic treatment on postoperative outcomes in patients receiving early enteral nutrition.</p><p><strong>Methods: </strong>We reviewed 210 living-donor liver transplantation procedures and retrospectively analyzed the postoperative outcomes with and without perioperative synbiotic treatment (live lactic acid bacteria, bifidobacteria, and oligosaccharides) 5 days before and after living-donor liver transplantation.</p><p><strong>Results: </strong>The synbiotic group (n = 34) had significantly fewer male donors (38.2% vs. 61.9%, p = 0.011) and a higher proportion of ABO-incompatible grafts (52.9% vs. 25.6%, p = 0.021) than the non-synbiotic group (n = 176). The incidence of sepsis was significantly lower in the synbiotic group than in the non-synbiotic group (0% vs. 7.4%, p = 0.029), with a lower incidence rate of sepsis due to bacteremia with intestinal bacteria (0% vs. 4.6%, p = 0.089). There were no significant differences in the proportions of acute rejection, small-for-size graft syndrome, or postoperative liver function between the two groups. Furthermore, there was no significant difference in the graft survival rates after LDLT between two groups. (p = 0.24).</p><p><strong>Conclusion: </strong>Perioperative synbiotic treatment prevents post-transplant sepsis, even with early enteral nutrition.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"475-482"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery Today
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1